Within highly inflammatory BC TMEs, immune infiltration is correlated to the presence of tumoral hormone receptors, and is variable for ER+, HER2+, and TNBC (Segovia-Mendoza and Morales-Montor, 2019). This evidence concerns the gene NR4A1 and breast cancer.